
Sunday, November 10, 2024 4:47:26 PM
KEGS was profitable in the 2nd Quarter of 2024.
KEGS cash on hand went up by over $60,000. in the 2nd Quarter of 2024.
KEGS has verifiable assets, 4 properties in New York.
KEGS is now delivering beer to 45 states plus DC.
KEGS beer is available to purchase in Canada.
KEGS 1812 beer has won multiple awards in multiple years in multiple competitions.
KEGS recently won New York Amber Ale Brewer of the Year Award.
KEGS has purchased a new restaurant in Watertown, NY now named 1812 on the River.
KEGS has a restaurant in Sackets Harbor, NY now called 1812 on the Lake.
KEGS has its own brewery & bottling processing facility in Watertown that is 13,000 sq feet (different than the restaurant).
KEGS has addressed the $13.7 million in debt and the note holders have tentatively agreed not to convert until market cap reaches $100 million
Also Breaking News: Brian Mclain has offered to sell, or sold, 100 million shares for $100,000 according to a SEC document, form 144/A, filed on 7-29-2024: https://www.otcmarkets.com/filing/html?id=17711190&guid=YBO-knmv0E5eJth
I will let time tell the truth for the shareholders of KEGS!
Lets Go KEGS! More Good News!
https://www.otcmarkets.com/stock/KEGS/news
.

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM